STAND. COM. REP. NO. 2954

 

Honolulu, Hawaii

                  

 

RE:    H.B. No. 2056

       H.D. 1

       S.D. 1

 

 

 

Honorable Colleen Hanabusa

President of the Senate

Twenty-Fifth State Legislature

Regular Session of 2010

State of Hawaii

 

Madam:

 

     Your Committee on Commerce and Consumer Protection, to which was referred H.B. No. 2056, H.D. 1, S.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO PHARMACIST LICENSURE,"

 

begs leave to report as follows:

 

     The purpose of this measure is to:

 

     (1)  Increase the geographic locations where an individual can obtain the practical experience that is required to become a licensed pharmacist in Hawaii; and

 

     (2)  Require that the necessary practical experience be predominantly related to the practice of pharmacy, rather than requiring the practical experience to occur in a pharmacy.

 

     Specifically, this measure includes the District of Columbia and the United States territories of Puerto Rico, the Northern Mariana Islands, the Virgin Islands, Guam, and America Samoa as places where practical experience can be earned toward the fifteen hundred hour requirement to become a licensed pharmacist in this State.

 

     Testimony in support of this measure was submitted by the Board of Pharmacy, the University of Hawaii at Hilo College of Pharmacy, Kaiser Permanente, CVS Caremark/Longs Drugs, the President of the University of Hawaii at Hilo College of Pharmacy Class of 2013, and one private citizen.  Written testimony presented to the Committee may be reviewed on the Legislature's website.

 

     Your Committee finds that the University of Hawaii at Hilo College of Pharmacy is the only pharmacy program in the Pacific Basin and that its students come from many territories and countries in the Pacific region who will likely practice pharmacy in a variety of healthcare settings.  Your Committee also finds that it is important for the College of Pharmacy's practical experience program to reflect what will be the reality of practice for many of its students, which is in pharmaceutical settings beyond the traditional pharmacy, including clinics and acute care facilities.

 

     As affirmed by the record of votes of the members of your Committee on Commerce and Consumer Protection that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2056, H.D. 1, S.D. 1, and recommends that it pass Third Reading.

 

Respectfully submitted on behalf of the members of the Committee on Commerce and Consumer Protection,

 

 

 

____________________________

ROSALYN H. BAKER, Chair